Literature DB >> 33327733

Metabolic Syndrome Predisposes to Osteoarthritis: Lessons from Model System.

Sampath Samuel Joshua Pragasam1, Vijayalakshmi Venkatesan1.   

Abstract

OBJECTIVE: The present study aims to assess for temporal changes in tibial subchondral bone and cartilage in WNIN/Gr-Ob rats (portraying obesity, insulin resistance, dyslipidemia, impaired glucose tolerance, hypertension) in comparison with Wistar controls (WNIN) using anthropometry, micro-computed tomography (micro-CT), scanning electron microscopy (SEM), histopathology, enzyme-linked immunosorbent assay (ELISA), and immunofluorescence.
DESIGN: Body weight, abdominal circumference, body mass index (BMI), lean/fat mass, serum tumor necrosis factor (TNF)-α levels were measured (ELISA), followed by ultrastructural analysis of tibial subchondral bone (micro-CT) and cartilage architecture (histopathology and SEM) in WNIN/Gr-Ob and WNIN rats with age (3, 6 and 9 months). Additionally, primary cultures of articular chondrocytes isolated from 6-month-old WNIN/Gr-Ob and WNIN rats were assessed for matrix metalloproteinase (MMP)-13 and Collagen type II (COL2A1) by immunofluorescence.
RESULTS: WNIN/Gr-Ob rats exhibited frank obesity with increased BMI, lean and fat mass vis-à-vis significantly higher levels of serum TNF-α (6>9>3 months) as compared with the controls. With an increase in BMI, WNIN/Gr-Ob rats presented with tibial cartilage fibrillation, erosion, osteophyte formation (6 months) and subchondral bone cyst (9 months) confirmed by histology and SEM. An increase in subchondral trabecular bone volume (sclerosis with decreased plate porosity) was observed in all ages in WNIN/Gr-Ob rats compared to their Control. Gaining insights, primary cultures of articular chondrocytes complemented with altered cellular expressions of COL2A1 and MMP-13 from WNIN/Gr-Ob rats, indicating osteoarthritis (OA) progression.
CONCLUSION: Multiple metabolic perturbations featured in WNIN/Gr-Ob rats were effective to induce spontaneous OA-like degenerative changes affecting knee joints akin to human OA.

Entities:  

Keywords:  WNIN/Gr-Ob; chondrocytes; knee joints; metabolic syndrome; obesity; osteoarthritis

Mesh:

Year:  2020        PMID: 33327733      PMCID: PMC8808954          DOI: 10.1177/1947603520980161

Source DB:  PubMed          Journal:  Cartilage        ISSN: 1947-6035            Impact factor:   3.117


  39 in total

Review 1.  Metabolic syndrome-associated osteoarthritis.

Authors:  Alice Courties; Jérémie Sellam; Francis Berenbaum
Journal:  Curr Opin Rheumatol       Date:  2017-03       Impact factor: 5.006

2.  Optimization of chondrocyte isolation and characterization for large-scale cartilage tissue engineering.

Authors:  Adelola O Oseni; Peter E Butler; Alexander M Seifalian
Journal:  J Surg Res       Date:  2012-06-19       Impact factor: 2.192

3.  Association between metabolic syndrome, radiographic knee osteoarthritis, and intensity of knee pain: results of a national survey.

Authors:  Doosup Shin
Journal:  J Clin Endocrinol Metab       Date:  2014-04-29       Impact factor: 5.958

4.  Spatial and temporal changes of subchondral bone proceed to microscopic articular cartilage degeneration in guinea pigs with spontaneous osteoarthritis.

Authors:  T Wang; C-Y Wen; C-H Yan; W-W Lu; K-Y Chiu
Journal:  Osteoarthritis Cartilage       Date:  2013-01-09       Impact factor: 6.576

5.  Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis.

Authors:  Frank C Tinsley; Gersh Z Taicher; Mark L Heiman
Journal:  Obes Res       Date:  2004-01

Review 6.  Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!).

Authors:  F Berenbaum
Journal:  Osteoarthritis Cartilage       Date:  2012-11-27       Impact factor: 6.576

Review 7.  Obesity & osteoarthritis.

Authors:  Lauren K King; Lyn March; Ananthila Anandacoomarasamy
Journal:  Indian J Med Res       Date:  2013       Impact factor: 2.375

8.  Suppressive Effects of Insulin on Tumor Necrosis Factor-Dependent Early Osteoarthritic Changes Associated With Obesity and Type 2 Diabetes Mellitus.

Authors:  Daisuke Hamada; Robert Maynard; Eric Schott; Christopher J Drinkwater; John P Ketz; Stephen L Kates; Jennifer H Jonason; Matthew J Hilton; Michael J Zuscik; Robert A Mooney
Journal:  Arthritis Rheumatol       Date:  2016-06       Impact factor: 10.995

9.  Protection against osteoarthritis in experimental animals by nanogold conjugated snake venom protein toxin gold nanoparticle-Naja kaouthia cytotoxin 1.

Authors:  Antony Gomes; Partha Pratim Saha; Tanmoy Bhowmik; Anjan Kumar Dasgupta; Subir Chandra Dasgupta
Journal:  Indian J Med Res       Date:  2016-12       Impact factor: 2.375

10.  Early Changes of Articular Cartilage and Subchondral Bone in The DMM Mouse Model of Osteoarthritis.

Authors:  Hang Fang; Lisi Huang; Ian Welch; Chris Norley; David W Holdsworth; Frank Beier; Daozhang Cai
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

View more
  2 in total

1.  Human placental mesenchymal stromal cell therapy restores the cytokine efflux and insulin signaling in the skeletal muscle of obesity-induced type 2 diabetes rat model.

Authors:  Nagasuryaprasad Kotikalapudi; Samuel Joshua Pragasam Sampath; Sukesh Narayan Sinha; R Bhonde; Sathish Kumar Mungamuri; Vijayalakshmi Venkatesan
Journal:  Hum Cell       Date:  2022-01-29       Impact factor: 4.174

2.  Beneficial effects of secretome derived from mesenchymal stem cells with stigmasterol to negate IL-1β-induced inflammation in-vitro using rat chondrocytes-OA management.

Authors:  Samuel Joshua Pragasam Sampath; Subha Narayan Rath; Nagasuryaprasad Kotikalapudi; Vijayalakshmi Venkatesan
Journal:  Inflammopharmacology       Date:  2021-09-21       Impact factor: 4.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.